Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists create pigs resistant to PRRS
PRRS can lead to severe breathing problems in piglets and breeding failures in pregnant females.
Gene-editing technique could improve animal health

Scientists have used advanced gene editing techniques to create pigs that show signs of resistance to a major viral disease.

Writing in the journal Plos Pathogens, researchers describe how they produced pigs that are completely resistant to porcine reproductive and respiratory syndrome (PRRS).

The team claims the pigs are otherwise healthy and the change introduced using gene-editing technology should not affect their ability to stave off other infections.

“Genome-editing offers opportunities to boost food security be reducing waste and losses from infectious diseases, as well as improving animal welfare by reducing the burden of disease,” explained lead researcher Professor Alan Archibald of The Roslin Institute.

PRRS can lead to severe breathing problems in piglets and breeding failures in pregnant females. Endemic in most pig-producing companies, vaccines have, on the whole, failed to prevent the spread of the virus. In Europe alone, the disease is thought to cost the industry some €1.5billion every year.

Research conducted in the past shows that the PRRS virus targets immune cells called macrophages. A molecule on the surface of these cells called CD163 is essential in enabling the PRRS virus to establish an infection.

In the study, scientists used a gene editing tool called CRISPR/Cas9 to cut out a small section of the CD163 gene in the pigs’ DNA that interacts with the PRRS virus. Research shows that this change prevents the virus from causing infection.

Professor Bruce Whitelaw, interim director of the Roslin Institute described the project as an ‘elegant demonstration’ of how precise genome editing can be.

“We have deleted a single exon from the CD163 gene. The opportunity to use this technology to Improve animal health and productivity presents an exciting approach to address the food security and one health challenges,” he said.

The study was funded by the Biotechnology and Biological Sciences Research (BBSRC) Animal Research Club and Genus. 

Become a member or log in to add this story to your CPD history

Webinar to explore AMR in vet dentistry

News Story 1
 The WSAVA has invited veterinary professionals to a webinar on responsible antibiotic usage in dentistry.

On 19 November 2025, at 1am, Dr J Scott Weese and Dr Brooke Niemiec will share the latest advice for antimicrobial use. They will present research on oral bacterology, and explain how attendees can choose appropriate antibiotics.

The session will cover pre-, intra- and post-operative guidelines, with recommendations for various pathologies.

The webinar is designed to support veterinary professionals to make informed decisions and tackle antimicrobial resistance.

Attendees can register here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com